Gene expression profiling in the prediction of response of multiple myeloma to the proteasome inhibitor PS-341.

被引：0
|
作者：
Shaughnessy, J [1 ]
Zhan, FH [1 ]
McCastlain, K [1 ]
Tian, EM [1 ]
Tricot, G [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1512
引用
收藏
页码：390A / 390A
页数：1
相关论文
共 50 条
  • [31] Osteoclast Gene Expression Profiling in Multiple Myeloma
    Moreaux, J.
    Hose, D.
    Reme, T.
    Moine, P.
    Mahtouk, K.
    Moos, M.
    Requirand, G.
    De Vos, J.
    Rossi, J. F.
    Goldschmidt, H.
    Klein, B.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S153 - S153
  • [32] Metascoring and gene expression profiling in multiple myeloma
    Meissner, T.
    Seckinger, A.
    Reme, T.
    Hielscher, T.
    Moehler, T.
    Neben, K.
    Goldschmidt, H.
    Klein, B.
    Hose, D.
    ONKOLOGIE, 2011, 34 : 242 - 242
  • [33] A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma
    A K Mitra
    T Harding
    U K Mukherjee
    J S Jang
    Y Li
    R HongZheng
    J Jen
    P Sonneveld
    S Kumar
    W M Kuehl
    V Rajkumar
    B Van Ness
    Blood Cancer Journal, 2017, 7 : e581 - e581
  • [34] A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma
    Mitra, A. K.
    Harding, T.
    Mukherjee, U. K.
    Jang, J. S.
    Li, Y.
    HongZheng, R.
    Jen, J.
    Sonneveld, P.
    Kumar, S.
    Kuehl, W. M.
    Rajkumar, V.
    Van Ness, B.
    BLOOD CANCER JOURNAL, 2017, 7 : e581 - e581
  • [35] Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model
    LeBlanc, R
    Catley, LP
    Hideshima, T
    Lentzsch, S
    Mitsiades, CS
    Mitsiades, N
    Neuberg, D
    Goloubeva, O
    Pien, CS
    Adams, J
    Gupta, D
    Richardson, PG
    Munshi, NC
    Anderson, KC
    CANCER RESEARCH, 2002, 62 (17) : 4996 - 5000
  • [36] An oral proteasome inhibitor for multiple myeloma
    Pratt, Guy
    LANCET ONCOLOGY, 2014, 15 (13): : 1417 - 1418
  • [37] Proteasome inhibitor for treatment of multiple myeloma
    Ahmad, K
    LANCET ONCOLOGY, 2005, 6 (08): : 546 - 546
  • [38] Proteasome inhibitor therapy in multiple myeloma
    Chauhan, D
    Hideshima, T
    Mitsiades, C
    Richardson, P
    Anderson, KC
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 686 - 692
  • [39] Proteasome inhibitor PS-341 and docetaxel: sequence of administration may be crucial
    Garfield, D
    LANCET ONCOLOGY, 2001, 2 (12): : 714 - 714
  • [40] Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer
    Adams, J
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) : 493 - 500
12345